Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene® HSV 1&2

CINCINNATI -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has received FDA clearance for two new molecular assays for the detection of Herpes Simplex Virus Type 1 (HSV-1) and Type 2 (HSV-2), to be run on its illumigene® molecular platform. The illumigene® HSV 1&2 assays, launched earlier this year in Europe, are now [...]

Illumina Names Sanjay Chikarmane as Senior Vice President and General Manager of Enterprise Informatics

SAN DIEGO - Illumina Inc. (NASDAQ:ILMN) today announced that Sanjay Chikarmane has been named Senior Vice President and General Manager of Illumina’s Enterprise Informatics business. Chikarmane will lead the development and commercialization of products and services aimed at turning genomic data into actionable information for researchers and clinicians. He will report to Illumina President, Francis [...]

Macrogen Named PacBio Certified Service Provider

MENLO PARK, Calif. -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced that Macrogen Inc of Korea has been named a PacBio Certified Service Provider. The PacBio Certified Service Provider Program is a global network of validated service organizations utilizing PacBio's sequencing technology. PacBio Certified Service Providers [...]

Huntingdon Life Sciences and Harlan Laboratories announce new equity funding

Huntingdon (UK) -- Huntingdon Life Sciences (HLS) and Harlan Laboratories, soon to be called Envigo, is pleased to announce that a group of institutional investors has committed up to $125 million in a minority equity financing that can be used to fund future growth initiatives. Brian Cass, CEO, commented: “We recently announced our rebranding of [...]

Contextual Genomics and the Personalized Medicine Initiative Sign Sequencing Technology Leader Illumina to National Access Project

Vancouver, BC –– Contextual Genomics, developers of genomics-based cancer tests, and the Personalized Medicine Initiative (PMI), an organization bringing molecular-based medicine to Canadians, are pleased to announce global sequencing technology leader, Illumina, Inc. has joined its National Access Project consortium. The National Access Project aims to make genomics testing a standard practice in cancer care [...]

Thermo Fisher Scientific Partners with the CDC to Accelerate Global Microbial Identification

CARLSBAD, Calif. -- Thermo Fisher ScientificThrough a successful partnership with the Special Bacteriology Reference Laboratory at the Centers for Disease Control and Prevention (CDC), Thermo Fisher Scientific has developed an advanced software solution that enables global public health laboratories to directly access the CDC’s MicrobeNet online virtual reference lab database. Now, researchers can more quickly [...]

Hellmann Logistics Selects Morpho’s Itemiser DX for Enhanced Air Cargo Screening

ANDOVER, Mass. –– Morpho (Safran), through its subsidiary Morpho Detection, today announced contracts from Hellmann Worldwide Logistics to supply and service Itemiser® DX explosives trace detectors (ETD) to screen air cargo. Following an initial contract in 2014, Hellmann recently purchased additional Itemiser DX units to replace legacy systems and ensure its continued compliance with the [...]

10X Genomics Selects Kapa Biosystems as a Reagents Supplier for the GemCode™ Platform

PLEASANTON, Calif. and WILMINGTON, Mass.—— 10X Genomics and Kapa Biosystems today announced that Kapa’s DNA library preparation reagents have been incorporated into the GemCode Platform, enabling a more streamlined workflow generating high quality sequencing data. The GemCode Platform is a unique molecular barcoding and analysis platform that consists of instrumentation, reagents and software to generate [...]

MyDx Names Tom Gruber as New CEO

SAN DIEGO, CA -- MyDx, Inc. (OTCQB: MYDX), creator of MyDx™ (My Diagnostic), the first battery operated, handheld, chemical analyzer for consumers, has appointed Tom Gruber as the new Chief Executive Officer effective July 10, 2015. Tom is currently the company's Chief Financial Officer and Chief Operating Officer and will continue to serve on MyDx's [...]

REICHERT LIFE SCIENCES TO SHOWCASE NEXT-GENERATION DRUG DISCOVERY SOLUTIONS AT THE 29TH ANNUAL SYMPOSIUM OF THE PROTEIN SOCIETY

BUFFALO, N.Y. –– Reichert Technologies, a business unit of AMETEK Ultra Precision Technologies, will showcase its latest Surface Plasmon Resonance (SPR) innovations and capabilities at the 29th Annual Symposium of the Protein Society. The Annual Symposium is a prominent scientific forum that highlights the latest advances in protein science. This year’s event takes place between [...]

Access IBO on Knowledge Center